Ryan Cross
Ovaries in a dish? Lab-grown eggs are on the horizon
George Church is known for pushing the boundaries of biology. Now one of his latest projects could have enormous implications ...
Extrachromosomal DNA: The unique clues scientists are using to outfox cancer
Human cells are not supposed to have extra bits of DNA floating around, so [Paul] Mischel described the peculiar substance ...
First COVID-19 vaccines on track to arrive late 2020, faster than thought possible
Three companies with funding from the US government—AstraZeneca, Johnson & Johnson, and Moderna—are on track to distribute the first commercial ...
Gene therapy pioneer James Wilson makes a comeback after disastrous start
Twenty years ago, a young man named Jesse Gelsinger was injected with a large dose of gene-shuttling viruses designed in ...
‘Proudly GMO’ probiotic takes aim at hangovers. Can it ease consumer fear of biotechnology?
On [August 17], a San Francisco-based start-up called ZBiotics celebrated the launch of its first product in a fitting way: ...
Can the RNA editing race challenge the potential of CRISPR’s DNA editing?
RNA, a short-lived cousin to its better-known partner DNA, is the blueprint for protein production in cells. [Biotech entrepreneur Joshua] ...
‘Epitranscriptomics’: New field aims to treat cancer through RNA code
It’s not every day that a biotech investor stumbles across an entirely new field of science. And frankly, Carlo Rizzuto ...
‘Software of life’ and why messenger RNA could be the next big thing in pharmaceuticals
“Why are we so passionate about messenger RNA?” Moderna President Stephen Hoge asked the attentive audience. “It starts with the ...
‘The potential here is huge’: Using exosomes to package and deliver drug therapy
Millions of tiny bubbles, released from cells and packaged with molecular mail, are racing through your bloodstream right now. And ...
Reversing traumatic brain injury: Memory-enhancing drug might help
[T]raumatic brain injury can be permanent. There are no drugs to reverse the cognitive decline and memory loss, and any ...
1 in 5 healthy adults may carry rare genetic disease mutations
A new pair of studies is the first ever randomized clinical trials evaluating whole genome sequencing in healthy people. They ...
New GE rice variety boosts plant’s immune system to fight multiple diseases at once
Plants don’t have a bloodstream to circulate immune cells. Instead, they use receptors on the outsides of their cells to ...
Whole genome sequencing could have huge impact on medicine
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. "It sounds kind of ...